DCAF10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.764200E-01
Normal-vs-Stage2
5.225000E-01
Normal-vs-Stage3
9.659200E-03
Normal-vs-Stage4
6.943400E-01
Stage1-vs-Stage2
2.078600E-01
Stage1-vs-Stage3
7.644100E-03
Stage1-vs-Stage4
7.483800E-01
Stage2-vs-Stage3
5.9865999999964E-05
Stage2-vs-Stage4
1.416990E-01
Stage3-vs-Stage4
1.155360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.399800E-01
Normal-vs-AfricanAmerican
9.950400E-01
Normal-vs-Asian
4.235600E-01
Caucasian-vs-AfricanAmerican
5.238200E-01
Caucasian-vs-Asian
6.326400E-01
AfricanAmerican-vs-Asian
4.013600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.158400E-01
Normal-vs-Female
7.393000E-01
Male-vs-Female
4.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.687800E-01
Normal-vs-Age(41-60Yrs)
9.418800E-01
Normal-vs-Age(61-80Yrs)
5.864600E-01
Normal-vs-Age(81-100Yrs)
3.305000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.662600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.298200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.737800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.330000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.157440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.971800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.507970E-01
Normal-vs-Daily Drinker
1.583840E-01
Normal-vs-Weekly Drinker
6.109400E-01
Normal-vs-Occasional Drinker
9.776600E-01
Normal-vs-Social Drinker
6.925000E-01
Non Drinker-vs-Daily Drinker
6.674200E-01
Non Drinker-vs-Weekly Drinker
1.628390E-01
Non Drinker-vs-Occasional Drinker
7.893900E-02
Non Drinker-vs-Social Drinker
3.098200E-02
Daily Drinker-vs-Weekly Drinker
1.292830E-01
Daily Drinker-vs-Occasional Drinker
5.588100E-02
Daily Drinker-vs-Social Drinker
2.264200E-02
Weekly Drinker-vs-Occasional Drinker
4.880200E-01
Weekly Drinker-vs-Social Drinker
1.765450E-01
Occasional Drinker-vs-Social Drinker
4.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.393000E-01
Normal-vs-Grade 2
5.980300E-02
Normal-vs-Grade 3
7.980200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.020400E-01
Grade 1-vs-Grade 3
4.800800E-01
Grade 1-vs-Grade 4
1.393000E-01
Grade 2-vs-Grade 3
6.153000E-01
Grade 2-vs-Grade 4
5.980300E-02
Grade 3-vs-Grade 4
7.980200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.432200E-01
Normal-vs-NonDiabetic
6.083800E-01
Diabetic-vs-NonDiabetic
2.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.093760E-01
Normal-vs-NoPancreatitis
6.263000E-01
Pancreatitis-vs-NoPancreatitis
1.819990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.062400E-01
Normal-vs-N1
5.216600E-01
N0-vs-N1
2.857800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.497000E-01
Normal-vs-TP53-NonMutant
8.724600E-01
TP53-Mutant-vs-TP53-NonMutant
2.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
